Defect alert


Phebra has initiated a product defect alert for bottles of Ospolot (sulthiame) 200mg tablets Phebra Pty Ltd, in conjunction with the TGA, made the announcement on Thursday after it was identified that the child-resistant caps may not function correctly. “If this occurs, a child may be able to open a bottle and access the medicine,

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous ‘Smart drugs’ earn fine
Next Restoring a sense of dignity and strength